December 11, 2023 08:19 AM ESTUpdated 08:33 AM
Pharma
FDA+

ICER un­veils lat­est re­port on 'un­sup­port­ed' drug price in­creas­es

Zachary Brennan

Senior Editor

The drug pric­ing watch­dog known as the In­sti­tute for for Clin­i­cal and Eco­nom­ic Re­view on Mon­day un­veiled its an­nu­al re­port on what it says are …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times